EUVIMEDEUVIMED entdecken
Open Access

ARID1A restrains EMT and stemness of ovarian cancer cells through the Hippo pathway

Shouying Xu, Chongying Zhu, Qiang Xu, Zihao An, Shu Xu, Ge Xuan, Chao Lin, Chao Tang

International Journal of Oncology · 2024

DOI: 10.3892/ijo.2024.5664 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Oncology, 2024. Verfasst von Shouying Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Child Health of the Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310052, P.R…. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Hippo Signaling Pathway, Neoplastic Stem Cells, Ovarian Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genes encoding subunits of SWI/SNF (BAF) chromatin‑remodeling complexes are recurrently mutated in a broad array of tumor types, and among the subunits, ARID1A is the most frequent target with mutations. In the present study, it was reported that ARID1A inhibits the epithelial‑mesenchymal transition (EMT) and stemness of ovarian cancer cells, accompanied by reduced cell viability, migration and colony formation, suggesting that ARID1A acts as a tumor suppressor in ovarian cancer. Mechanistically, ARID1A exerts its inhibitory effects on ovarian cancer cells by activating the Hippo signaling pathway. Conversely, the overexpression of a gain‑of‑function transcriptional co‑activator with PDZ‑binding motif (TAZ) mutant (TAZ‑Ser89) effectively reverses the effects induced by ARID1A. In addition, activation of Hippo signaling apparently upregulates ARID1A protein expression, whereas ectopic expression of TAZ‑Ser89 results in the markedly decreased ARID1A levels, indicating a feedback of ARID1A‑TAZ in regulating ovarian cancer cell EMT and stemness. Thus, the present study uncovered the role of ARID1A through the Hippo/TAZ pathway in modulating EMT and stemness of ovarian cancer cells, and providing with evidence that TAZ inhibitors could effectively prevent initiation and metastasis of ovarian cancer cases where ARID1A is lost or mutated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionHippo Signaling PathwayNeoplastic Stem CellsOvarian NeoplasmsTranscription FactorsFemaleHumansCell Line, TumorCell MovementCell ProliferationDNA-Binding ProteinsGene Expression Regulation, NeoplasticNuclear ProteinsProtein Serine-Threonine KinasesSignal TransductionTranscriptional Coactivator with PDZ-Binding Motif Proteins

Stichwörter der Autor:innen

AT‑rich interaction domain 1AHippoovarian cancerstemnesstranscriptional co‑activator with PDZ‑binding motif

Substanzen

ARID1A protein, humanDNA-Binding ProteinsNuclear ProteinsProtein Serine-Threonine KinasesTranscription FactorsTranscriptional Coactivator with PDZ-Binding Motif ProteinsWWTR1 protein, human

Autor:innen und Institutionen

  • National Clinical Research Center for Child Health of the Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310052, P.R. China.
  • The Department of Obstetrics and Gynecology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, P.R. China.
  • Department of Gynecology, Ningbo Women and Children's Hospital, Ningbo, Zhejiang 315012, P.R. China.
  • Department of Neurosurgery, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310052, P.R. China.

Zitieren

APA

Xu, S., Zhu, C., Xu, Q., An, Z., Xu, S., Xuan, G., Lin, C., & Tang, C. (2024). ARID1A restrains EMT and stemness of ovarian cancer cells through the Hippo pathway. International Journal of Oncology. https://doi.org/10.3892/ijo.2024.5664

Vancouver

Xu S, Zhu C, Xu Q, An Z, Xu S, Xuan G, et al. ARID1A restrains EMT and stemness of ovarian cancer cells through the Hippo pathway. International Journal of Oncology. 2024. doi:10.3892/ijo.2024.5664

BibTeX
@article{Xu2024,
  author = {Xu, Shouying and Zhu, Chongying and Xu, Qiang and An, Zihao and Xu, Shu and Xuan, Ge and Lin, Chao and Tang, Chao},
  title = {ARID1A restrains EMT and stemness of ovarian cancer cells through the Hippo pathway},
  journal = {International Journal of Oncology},
  year = {2024},
  doi = {10.3892/ijo.2024.5664}
}
Kostenlos starten →